Young scientist works in modern biologic

VitriLife® Technology Overview

VitriLife® is the 1st scalable vitrification platform designed for the long-term ambient temperature stabilization of microbial and biological materials. 

  • Designed as a more efficient, scalable, and cost-effective alternative to lyophilization resulting in superior stabilization for real world environments.
     

  • Immobilizes biological materials in a sugar glass matrix.

  • Arrests rotational and translational motion of molecules.

  • Achieves significant increases to product shelf life and improves activity yields.

  • Maintains higher titer after drying and subsequent storage.

  • Reduces logistical burden of cold chain, packaging, and shipping costs.

  • Enables micronization (milling foam to powder) without product damage.

  • Enables formulation of combination/multi-component products. ​
     

  • Instantaneous reconstitution at site of delivery.

  • The cornerstone of the VitriLife platform is our patented state-of-the-art drying by boiling process known as preservation by vaporization (PBV).   

 

iStock-512825222.jpg

Expertise in the stabilization and delivery of a wide range of biologics such as: ​

  • Vaccines (e.g. mRNA, live viral and bacterial vaccines)

  • Therapeutic Proteins

  • Microbiome Therapeutics 

  • Probiotics

  • Agricultural Biologicals (e.g. bacteria, fungi)

  • Enzymes 

 

and much more...

How does VitriLife technology compare against other drying technologies?
Screen Shot 2021-09-23 at 4.36.15 PM.png
VitriLife technology allows the scalable production of thermostable vaccines and other biologics in vials and/or in bulk format
Screen Shot 2021-09-23 at 4.35.26 PM.png